Showing results (41-50 of 2,355) with videos related to

Sort By:
Pageof 236
Clinical Neuropharmacology|December 1, 1993
Sumatriptan does not affect vasopressin secretion in humansT Barreca, R Franceschini, A Cataldi, et al.
Clinical Neuropharmacology|January 1, 1984
Estrogen and progesterone receptors in intracranial tumorsR Martinez, M L Marcos, A Figueras, et al.
Clinical Neuropharmacology|January 1, 1984
Cytosolic and nuclear sex steroid receptors in meningiomaM Moguilewsky, B F Pertuiset, C Verzat, et al.
Clinical Neuropharmacology|December 1, 1982
Research design issues: antialuminum drug studies in Alzheimer's diseaseD Shore, R J Wyatt
Clinical Neuropharmacology|May 22, 2023
Characteristics and Treatments of Coronavirus Disease 2019 Patients Presenting With Persistent Hiccups: A Scoping ReviewMichael Boulis, Mary Boulis, Marianne Cosgrove, et al.
Clinical Neuropharmacology|May 14, 1998
Antiparkinsonian effects of BAM-1110, a novel ergoline derivative, in MPTP-treated cynomolgus monkeysS Kuno, E Mizuta, H Sakamoto, et al.
Clinical Neuropharmacology|May 14, 1998
Pediatric sertraline overdoseG Catalano, D S Cooper, M C Catalano, et al.
Clinical Neuropharmacology|May 14, 1998
Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuationsH Baas, S Harder, F Bürklin, et al.
Clinical Neuropharmacology|May 14, 1998
Emergence of obsessive--compulsive symptoms and tics during clozapine withdrawalM Poyurovsky, Y Bergman, D Shoshani, et al.
Clinical Neuropharmacology|May 14, 1998
Attentional deficits in Parkinson's disease: partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic alpha 1 agonistM A Bédard, F el Massioui, C Malapani, et al.
Pageof 236